Pink Sheet

Pink Sheet

@PharmaPinkSheet

Followers4.9K
Following373

Pink Sheet delivers analysis & commentary focused on regulatory implications, including high value perspectives from insiders & thought leaders across the globe

Global
Joined on December 18, 2012
Statistics

We looked inside some of the tweets by @PharmaPinkSheet and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
3 hours
Average replies
0
Average retweets
0
Average likes
0
Tweets with photos
10 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100

Rankings (sorted by number of followers)

831. globally and in category Services

Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC https://t.co/bfhj9z6OcT #PinkSheet

Virtual Adcom Vet Says In-Person Events May Be Better For Product Approval Recommendations https://t.co/7anXq6aWlp #PinkSheet

US FDA Eyes Ocular Risks With GlaxoSmithKline’s Myeloma Drug Belantamab https://t.co/eAfawWCBWK #PinkSheet

US FDA Announces Plans To Resume Domestic Inspections https://t.co/p0ckIVjIoi #PinkSheet

Recent And Upcoming FDA Advisory Committee Meetings https://t.co/B25oWP9o9t #PinkSheet

COVID-19: Gilead To Fill Remdesivir Supply Gap In EU https://t.co/4nDQDiwEdn #PinkSheet

EU Checks Pharma’s Appetite To Share Market Launch Intentions https://t.co/mzSwpdfpJH #PinkSheet

Regulators Want Tough Criteria For COVID-19 Vaccine Efficacy Trials https://t.co/NOylGzcGOp #PinkSheet

UK’s CMA Issues Fines Over Fludrocortisone https://t.co/p13wCpf13p #PinkSheet

Allergan Declines To Confirm Abicipar Pegol Fate https://t.co/zpd9ZHQChc #PinkSheet

#Covid19 has impacted the #consumerhealth and beauty products industries in different ways & #HBWInsight covers it all. Download your free #articlepack for the latest insights. https://t.co/4boBeDuK0b https://t.co/axinLQmoyQ

#Covid19 has impacted the #consumerhealth and beauty products industries in different ways & #HBWInsight covers it all. Download your free #articlepack for the latest insights. https://t.co/4boBeDuK0b https://t.co/axinLQmoyQ

Global Supply Chain Security Meets US Presidential Politics https://t.co/NVQVS2kKN6 #PinkSheet

US FDA Would Get Mandatory Recall Authority For Drugs Under House Funding Bill https://t.co/qFQzKC6SEP #PinkSheet

Scathing Report On UK Health Care System Failings Calls For Big Changes https://t.co/1Xb85H2oi4 #PinkSheet

EU Pharmaceutical Strategy Roadmap Seen As Weak On Innovation https://t.co/8NfNMSoC1Q #PinkSheet

Global Pharma Guidance Tracker – June 2020 https://t.co/eFp4qcV8N1 #PinkSheet

Five Compounds To Be Tested In UK’s TACTIC Coronavirus Study https://t.co/cRVmNKILKI #PinkSheet

Our #PinkSheet article pack includes:
➡️ #Drug Industry Perks Mostly Dropped from COVID19 Bill
➡️ TV Drug Advertising Spend Rising
➡️ Pricing Reform Prompt Canadian Business Rethink.

Download your copy here: https://t.co/ALtkRR9BL1 https://t.co/Nbcx7zC3sP

Our #PinkSheet article pack includes: ➡️ #Drug Industry Perks Mostly Dropped from COVID19 Bill ➡️ TV Drug Advertising Spend Rising ➡️ Pricing Reform Prompt Canadian Business Rethink. Download your copy here: https://t.co/ALtkRR9BL1 https://t.co/Nbcx7zC3sP

The Cost Of ‘Stacking’ Orphan Indications And A Case For Reform https://t.co/PqeooyDbJ0 #PinkSheet

Keeping Track: Biogen’s Aducanumab Headlines Midsummer Submission Round-Up https://t.co/BuTeVfPOWg #PinkSheet

Next Page